SEARCH

SEARCH BY CITATION

References

  • Barghorn S., Nimmrich V., Striebinger A. et al. (2005) Globular amyloid beta-peptide oligomer – a homogenous and stable neuropathological protein in Alzheimer’s disease. J. Neurochem. 95, 834847.
  • Bellucci A., Luccarini I., Scali C., Prosperi C., Giovannini M. G., Pepeu G. and Casamenti F. (2006) Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol. Dis. 23, 260272.
  • Butterfield D. A. and Lauderback C. M. (2002) Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32, 10501060.
  • Chishti M. A., Yang D. S., Janus C. et al. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276, 2156221570.
  • Colton C. A., Wilcock D. M., Wink D. A., Davis J., Van Nostrand W. E. and Vitek M. P. (2008) The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J. Alzheimers Dis. 15, 571587.
  • Daumas S., Sandin J., Chen K. S., Kobayashi D., Tulloch J., Martin S. J., Games D. and Morris R. G. (2008) Faster forgetting contributes to impaired spatial memory in the PDAPP mouse: deficit in memory retrieval associated with increased sensitivity to interference? Learn. Mem. 15, 625632.
  • Dinkova-Kostova A. T., Liby K. T., Stephenson K. K. et al. (2005) Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc. Natl Acad. Sci. USA 102, 45844589.
  • Drake J., Link C. D. and Butterfield D. A. (2003) Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid beta-peptide (1–42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging 24, 415420.
  • Dudal S., Krzywkowski P., Paquette J., Morissette C., Lacombe D., Tremblay P. and Gervais F. (2004) Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol. Aging 25, 861871.
  • Esposito L., Raber J., Kekonius L., Yan F., Yu G. Q., Bien-Ly N., Puolivali J., Scearce-Levie K., Masliah E. and Mucke L. (2006) Reduction in mitochondrial superoxide dismutase modulates Alzheimer’s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 26, 51675179.
  • Hartman R. E., Shah A., Fagan A. M., Schwetye K. E., Parsadanian M., Schulman R. N., Finn M. B. and Holtzman D. M. (2006) Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease. Neurobiol. Dis. 24, 506515.
  • Honda T., Honda Y., Favaloro F. G. Jr, Gribble G. W., Suh N., Place A. E., Rendi M. H. and Sporn M. B. (2002) A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production. Bioorg. Med. Chem. Lett. 12, 10271030.
  • Hyde L. A., Kazdoba T. M., Grilli M. et al. (2005) Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav. Brain Res. 160, 344355.
  • Jucker M. and Heppner F. L. (2008) Cerebral and peripheral amyloid phagocytes – an old liaison with a new twist. Neuron 59, 810.
  • Kang K. W., Lee S. J. and Kim S. G. (2005) Molecular mechanism of nrf2 activation by oxidative stress. Antioxid. Redox Signal. 7, 16641673.
  • Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W. and Glabe C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486489.
  • Keller J. N., Schmitt F. A., Scheff S. W., Ding Q., Chen Q., Butterfield D. A. and Markesbery W. R. (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 11521156.
  • Lee J. M., Li J., Johnson D. A., Stein T. D., Kraft A. D., Calkins M. J., Jakel R. J. and Johnson J. A. (2005) Nrf2, a multi-organ protector? FASEB J. 19, 10611066.
  • Li F., Calingasan N. Y., Yu F. et al. (2004) Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89, 13081312.
  • Liby K., Hock T., Yore M. M. et al. (2005) The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Cancer Res. 65, 47894798.
  • Liby K. T., Yore M. M. and Sporn M. B. (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 7, 357369.
  • Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A. and Cole G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 83708377.
  • Lin M. T. and Beal M. F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787795.
  • Liu L., Komatsu H., Murray I. V. and Axelsen P. H. (2008) Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. J. Mol. Biol. 377, 12361250.
  • Lovasic L., Bauschke H. and Janus C. (2005) Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer’s disease. Genes Brain Behav. 4, 197208.
  • Manczak M., Anekonda T. S., Henson E., Park B. S., Quinn J. and Reddy P. H. (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 14371449.
  • Melov S., Adlard P. A., Morten K. et al. (2007) Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2, e536.
  • Moreira P. I., Nunomura A., Nakamura M., Takeda A., Shenk J. C., Aliev G., Smith M. A. and Perry G. (2008) Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 44, 14931505.
  • Nunomura A., Moreira P. I., Takeda A., Smith M. A. and Perry G. (2007) Oxidative RNA damage and neurodegeneration. Curr. Med. Chem. 14, 29682975.
  • Park L., Anrather J., Zhou P., Frys K., Pitstick R., Younkin S., Carlson G. A. and Iadecola C. (2005) NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J. Neurosci. 25, 17691777.
  • Park L., Zhou P., Pitstick R. et al. (2008) Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc. Natl Acad. Sci. USA 105, 13471352.
  • Pratico D., Uryu K., Leight S., Trojanoswki J. Q. and Lee V. M. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 41834187.
  • Pratico D., Clark C. M., Liun F., Rokach J., Lee V. Y. and Trojanowski J. Q. (2002) Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 59, 972976.
  • Schipper H. M. (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 37, 19952011.
  • Stocker R. (2004) Antioxidant activities of bile pigments. Antioxid. Redox Signal. 6, 841849.
  • Town T., Laouar Y., Pittenger C., Mori T., Szekely C. A., Tan J., Duman R. S. and Flavell R. A. (2008) Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14, 681687.
  • Tran T. A., McCoy M. K., Sporn M. B. and Tansey M. G. (2008) The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection. J. Neuroinflammation 5, 14.
  • Verma A., Hirsch D. J., Glatt C. E., Ronnett G. V. and Snyder S. H. (1993) Carbon monoxide: a putative neural messenger. Science 259, 381384.
  • Wilcock D. M., Lewis M. R., Van Nostrand W. E., Davis J., Previti M. L., Gharkholonarehe N., Vitek M. P. and Colton C. A. (2008) Progression of amyloid pathology to Alzheimer’s disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. J. Neurosci. 28, 15371545.
  • Yoshiike Y., Minai R., Matsuo Y., Chen Y. R., Kimura T. and Takashima A. (2008) Amyloid oligomer conformation in a group of natively folded proteins. PLoS ONE 3, e3235.